WashU Expert: Trump’s new NAFTA won’t lower domestic drug prices | The Source | Washington University in St. Louis
President Donald Trump has touted his new United States-Mexico-Canada Agreement as a way to boost the American economy. It may not, however, have any impact on one of his other campaign promises: reducing prescription costs for U.S. consumers, says a drug pricing expert at Washington University in St. Louis.